Approximately 260 performers including 60 orchestra players, three vocal soloists, a passel of adult and college choristers and the Arkansas Symphony Children's Choir -- making its official debut -- ...
Tempus AI recently reported clinical validation results showing its Immune Profile Score (IPS) more accurately predicts outcomes for patients on immune checkpoint inhibitors than conventional ...
CHICAGO, February 12, 2026--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a collaboration with Median ...
Tempus AI, Inc. (NASDAQ:TEM) is one of the best Nancy Pelosi Stocks to buy in 2026. On January 27, Tempus AI, Inc. (NASDAQ:TEM) confirmed that its Immune Profile Score Test accurately predicts patient ...
Ambry Genetics launched RNA testing commercially in 2019 as +RNAinsight. Data from over 450,000 patients showed that 1 in 25 positive patients would have been missed without RNA data. The data also ...
Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced they will report financial results for the fourth quarter and full year 2025 on Tuesday, ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results